Psoriasis associated with HCV and exacerbated by interferon alpha: complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis.
Erkek
E
E
Karaduman
A
A
Akcan
Y
Y
Sökmensüer
C
C
Bükülmez
G
G
D017255:Acitretin / Q000627:therapeutic use; D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016174:Hepacivirus / Q000187:drug effects*; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D008297:Male; D011565:Psoriasis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*
D000998:Antiviral Agents; D016898:Interferon-alpha; D007641:Keratolytic Agents; D017255:Acitretin